NOVO NORDISK A/S News

Novo Nordisk Owner to Acquire Major Stake in Australian Life Sciences Firm

Seeking AlphaMay 15 08:34

Novo Nordisk to Test Obesity Drugs Including Wegovy in Alcohol Use

Novo Nordisk (NVO) is planning to test whether its weight loss drugs, including semaglutide, marketed as Wegovy, can impact alcohol use in patients with liver disease, according to an update the company has posted on a federal registry of clinical trials.

Seeking AlphaMay 14 13:42

Novo Nordisk's Wegovy Delivers: Long-Term Study Shows Sustained Weight Loss As Drugmaker Tries To Woo Insurers And Governments

Patients using Novo Nordisk's (NYSE:NVO) (OTC:NONOF) obesity treatment, Wegovy, have reportedly maintained an average weight loss of 10% over a four-year period, as per data revealed by the company on

BenzingaMay 14 01:26

Novo Nordisk A/S: Once-weekly and Once-monthly Mim8 Demonstrate Superior Reduction of Treated Bleeding Episodes Compared to On-demand and Prior Prophylaxis Treatment in People With Haemophilia A in the Frontier 2 Trial

Yahoo FinanceMay 13 10:49

One in Eight U.S. Adults Admits to GLP-1 Usage as Public Awareness Surges

Seeking AlphaMay 10 09:16

Novo Nordisk A/S Purchases B Shares Worth DKK 5,428 Million From Novo Holdings A/S Under the 2024 Share Repurchase Programme

Yahoo FinanceMay 6 13:40

Weight-loss Drug Competition Heats Up. Is Wegovy in Trouble?

Yahoo FinanceMay 3 10:35

Novo Nordisk Slides While Moderna Pops: Tale of Two Pharma Stocks

Yahoo FinanceMay 2 15:17

Novo Nordisk Sales up 26% Driven by GLP-1s, Misses 11% on Wegovy

Yahoo FinanceMay 2 11:55

Novo Nordisk CEO on Weight Loss Drugs' 'Exciting Growth Story'

Yahoo FinanceMay 2 09:13

Trending Tickers: Shell, Apple, Novo Nordisk and Standard Chartered

Yahoo FinanceMay 2 04:15

Novo Nordisk GAAP EPADR of DKK 5.68, Revenue of DKK 65.35B; Updates FY24 Outlook

Seeking AlphaMay 2 00:40

Novo Nordisk's Sales Increased by 22% in Danish Kroner and by 24% at Constant Exchange Rates to DKK 65.3 Billion in the First Three Months of 2024

Yahoo FinanceMay 2 00:30

Apple, Novo Nordisk Earnings, Jobless Claims: What to Watch

Yahoo FinanceMay 1 15:57

Eli Lilly Reports $2 Billion From Mounjaro, Zepbound in Q1 2024

Yahoo FinanceApr 30 12:23

Why These Analysts Are Bullish on Healthcare Stocks

Yahoo FinanceApr 29 16:04

Novo Nordisk A/S – Total Number of Voting Rights and Share Capital in Novo Nordisk A/S as of 26 April 2024

Yahoo FinanceApr 26 05:16

Novo Nordisk A/S – Reduction of the Share Capital

Yahoo FinanceApr 24 07:48

Weight Loss Drugs and the Many Use Cases in Medical Treatments

Yahoo FinanceApr 19 16:32

Eli Lilly Obesity Therapy Succeeds in Late-stage Trials for Sleep Disorder

Seeking AlphaApr 17 06:04